Veterinary Medicines

GALLIVAC IB88 lyofilizát na suspenziu pre kurčatá

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Download as PDF

Product identification

Medicine name:
GALLIVAC IB88 lyofilizát na suspenziu pre kurčatá
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
Target species:
  • Chicken (broiler)
Route of administration:
  • Ocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Live
    4.00
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Nebulisation use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/034/01-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 14/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."